1. Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH–DR5-B with Dual VEGFR2 and DR5 Receptor Specificity
   Anne V. Yagolovich et al, 2022, International Journal of Molecular Sciences CrossRef
2. Construction and validation of a novel tumor necrosis factor‐related apoptosis‐inducing ligand mutant MuR5S4‐TR
   Yaqin Zhao et al, 2024, Asia-Pacific Journal of Clinical Oncology CrossRef